@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_head { this: np:hasAssertion dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_assertion; np:hasProvenance dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_provenance; np:hasPublicationInfo dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_publicationInfo; a np:Nanopublication . dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_assertion a np:Assertion . dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_provenance a np:Provenance . dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_publicationInfo a np:PublicationInfo . } dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_assertion { miriam-gene:5156 a ncit:C16612 . lld:C1636667 a ncit:C7057 . dgn-gda:DGN035c7da2ea2c4ed080ecbdf15e0c4542 sio:SIO_000628 miriam-gene:5156, lld:C1636667; a sio:SIO_001121 . } dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_provenance { dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_assertion dcterms:description "[The 2001 World Health Organization (WHO) classification of myeloid malignancies included these MPDs under the broader category of chronic myeloproliferative diseases (CMPD), which also included chronic neutrophilic leukemia, chronic eosinophilic leukemia/hypereosinophilic syndrome (CEL/HES), and CMPD, unclassifiable. The revised 2008 WHO classification system featured the following changes: 1) the term CMPD was replaced by myeloproliferative neoplasm (MPN), 2) mast cell disease was formally included under the category of MPN, and 3) the subcategory of CEL/HES was reorganized into CEL not otherwise specified (CEL-NOS) and myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1; CEL-NOS remained a subcategory of MPN, whereas the latter neoplasms were now assigned a new category of their own.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:19472396; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP741266.RAsOnIb4WS-uWifsca9i35omwJhRCEedPH33HFnhP2c1s130_publicationInfo { this: dcterms:created "2016-05-13T12:47:21+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }